MolNFT v1 · #135959 · protein
Crystal structure of variable lymphocyte receptor (vlr) O13 (apo)
5UEI: “Crystal structure of variable lymphocyte receptor (vlr) O13 (apo)”. X-ray diffraction, 1 ligand (CL), 1 pocket (best druggability 0.36). MolNFT v1 #135959 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5UEI
- Type
- protein
- Length
- 246 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- O13
- Ligands
- CL
- Pockets
- 1 · best druggability 0.36
Structure
x-ray diffraction · 1 distinct chain · 10% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | O13 | protein | 246 | 10% helix, 16% strand | — |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 86 | 0.36 | 0.75 | 18 | CL |
Modifications
Observed in the structure: 5 disulfide (disulfide).
Compared structures
- 5UEI · Crystal Structure of Variable Lymphocyte Receptor (VLR) O13 (Apo) · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 5UEI · PDBe 5UEI
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.